Advertisement
Market Watch as on Jan 16, 2008

Market Watch as on Jan 16, 2008

We scan dozens of research reports from investment houses every fortnight to present you the six most relevant stock recommendations.

We scan dozens of research reports from investment houses every fortnight to present you the six most relevant stock recommendations.

HDFC  

Enam Securities: "HDFC enjoys one of the highest return on equity in the financial sector. It has sold 7.15% of its stake in Standard Life Insurance. Post sale, HDFC will start enjoying the economic benefit of its 72.5% stake in the venture. We are raising our target price to Rs 3,591 and maintain Outperformer rating."

For current stock prices and more details, click here

 
RecommendationBUY
Stock Price Rs 2845
One-year returns 82.42%
Profit Margin 53.30%
Q2 PE ratio 119.54
   
TATA SPONGE & IRON  
Dalal & Broacha: "The company plans to install 100 MW power plant at the pithead for utilisation of coal middlings. The power generated will be used for captive consumption and excess capacity will be supplied to the grid. This could add substantially to the bottom line. We recommend Buy."

For current stock prices and more details, click here

 
RecommendationBUY
Stock Price Rs 269
One-year returns 130.01%
Profit Margin 1393.91%
Q2 PE ratio 23.23
   
VARUN SHIPPING  
SBICAP Securities: "Varun has an LPG carrier fleet which is the largest in terms of both fleet size and cargo-carrying capacity. It has increased its presence in the lucrative offshore segment by acquiring two highend anchor handling tug supply. We initiate our coverage with a Buy rating and a price target of Rs 139."

For current stock prices and more details, click here
 
RecommendationBUY
Stock Price Rs 90
One-year returns 32.35%
Profit Margin 166.92%
Q2 PE ratio 23.27
   
BHEL  
Asit C Mehta: "Demand for power plant equipment is expected to remain strong. The company is planning to add further capacities. Outstanding order backlog of Rs 72,600 crore coupled with increased manufacturing capacities will drive growth over the medium term. We recommend Buy with a price target of Rs 2,970."

For current stock prices and more details, click here
 
RecommendationBUY
Stock Price Rs 2308
One-year returns 104.12%
Profit Margin 63.67%
Q2 PE ratio 164.27
   
BAJAJ HINDUSTHAN  
Edelweiss Securities: "In 2006-7, the company reported a meager 18% YoY growth in revenues, despite higher sugar capacity and doubling of distillery capacity. A highly leveraged balance sheet, lower single digit return ratios and non-supportive cash flows remain the biggest concerns. We maintain Sell recommendation."

For current stock prices and more details, click here
 
RecommendationSELL
Stock Price Rs 315
One-year returns 58.59%
Profit Margin -75.79%
Q2 PE ratio 52.3
   
SUN PHARMA  
Edelweiss Securities: "Sun Pharma has given steady top-line and bottom-line growth of 20%. Its domestic formulations segment has performed well. The US business is expected to be the company’s forte over the next couple of years. We maintain our Accumulate recommendation."

For current stock prices and more details, click here
 
RecommendationBUY
Stock Price Rs 1097
One-year returns 5.80%
Profit Margin 36.38%
Q2 PE ratio 112.17
   
All stock prices as on January 16. EPS is not annualised for computing PE ratio. Profit margins are based on half-yearly results for 2007-8. Some financial jargon: YoY = Year on Year; CAGR = Compounded annual growth rate; EBITDA = Earnings before interest, taxes, depreciation and amortisation.